USPTO 2015–2025 USPTO PatentsView US Corporation

Confluent Medical Technologies, Inc.

USPTO PatentsView assignee record - 7 granted patents across 10 technology areas, active 2017–2024. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

18.9

Avg claims per patent

+33%

5-year filing velocity

The verdict

Confluent holds 7 US patents across 10 technology areas, rank #34,870 of 50,000 tracked assignees.

#34,870
of 50,000 US assignees by volume: Top 47%
by Innovation Score (36.3/100): 18.9
avg claims per patent: +33%
filing velocity, last 5 yrs

Portfolio overview

Confluent Medical Technologies, Inc. has been granted 7 US utility patents between 2017 and 2024, placing Confluent Medical Technologies, Inc. at rank #34,870 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Confluent Medical Technologies, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Confluent sits between Comprehensive Biomarker Center Gmbh (7 patents, rank #34,866) and Consolidated Engineering Company, Inc. (7 patents, rank #34,874) - the closest US assignees by grant volume. The composite Innovation Score of 36.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 3 in the 2015–2019 window, a +33% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Confluent Medical Technologies, Inc.'s 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Confluent Medical Technologies, Inc. against peers pursuing similar technology classes.

Comprehensive Bio…

7
Compressor Contro…

7
Contipi Medical

7
Concurrent Comput…

7
Confluera

7
Conscience Inform…

7
Consider Provisio…

7
Consolidated Engi…

7
Confluent Medical ◀

7

What this shows Confluent holds 7 patents at rank #34,870, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Confluent

By rank, the assignees closest to #34,870 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Confluent's primary technology class.

Confluent's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

36 Top 47% higher than 53% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Confluent Medical Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	28.6%
2018	1	14.3%
2020	1	14.3%
2021	1	14.3%
2022	1	14.3%
2024	1	14.3%

Which technologies does Confluent Medical Technologies, Inc. patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 5

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 3

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 2

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 1

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 1

C22F - CHANGING THE PHYSICAL STRUCTURE OF NON-FERROUS METALS AND NON-FERROUS ALLOYS 1

C21D - MODIFYING THE PHYSICAL STRUCTURE OF FERROUS METALS; GENERAL DEVICES FOR HEAT TREATMENT OF FERROUS OR NON-FERROUS METALS OR ALLOYS; MAKING METAL MALLEABLE, e.g. BY DECARBURISATION OR TEMPERING 1

C22C - ALLOYS 1

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 1

Top 10 of 10 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Growing

Where it ranks

Overall rank by patents

#34,870

Across all tracked assignees

Innovation Score

36.3 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Confluent Medical Technologies, Inc. hold?

Confluent Medical Technologies, Inc. holds 7 US granted patents filed between 2017 and 2024, spanning 10 technology areas.

What is Confluent Medical Technologies, Inc.'s Innovation Score?

Confluent Medical Technologies, Inc. has an Innovation Score of 36.3 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Confluent Medical Technologies, Inc. focus on?

Confluent Medical Technologies, Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 5 patents. The company has filed patents in 10 CPC subclasses total.

Is Confluent Medical Technologies, Inc.'s patent filing rate increasing or decreasing?

Confluent Medical Technologies, Inc.'s recent filing velocity is +33% compared to the prior five-year period. The company is maintaining or growing its patent output.

What does claim depth mean for Confluent Medical Technologies, Inc.'s patents?

Confluent Medical Technologies, Inc.'s patents average 18.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Confluent Medical Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Confluent's 7 grants land it in the top 47% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Confluent ranks #34,870 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.